Immunoparalysis in critically ill children

Area of Science:

• Immunology
• Critical Care Medicine
• Pediatrics

Background:

• Immunoparalysis, a state of immune suppression, is associated with poor outcomes in the pediatric intensive care unit (PICU).
• Identifying patients at risk for immunoparalysis is crucial for predicting nosocomial infections and adverse clinical parameters.

Purpose of the Study:

• To identify patient groups at higher risk of immunoparalysis in the PICU.
• To correlate immunoparalysis status with increased risks of nosocomial infection and adverse clinical parameters.

Main Methods:

• An exploratory study involving 15 pediatric patients with multiple organ dysfunction syndrome.
• Measurement of monocyte human leucocyte antigen (HLA)-DR expression, and tumor necrosis factor (TNF)-α and interleukin (IL)-6 production via flow cytometry at three time points.
• Utilized the pediatric logistic organ dysfunction-2 score and established cut-off values for monocyte parameters to define immunoparalysis.

Main Results:

• Forty percent of patients were classified into the immunoparalysis group.
• The immunoparalysis group exhibited a higher frequency of nosocomial infections (p=0.011), increased vasoactive inotropic score (p=0.014), and longer hospital stay (p=0.036).
• Reduced classical monocyte HLA-DR expression and lower frequencies of TNF-α and IL-6 production within the first week identified immunoparalysis.

Conclusions:

• Reduced classical monocyte HLA-DR expression and lower TNF-α/IL-6 production are significant markers for immunoparalysis in critically ill children.
• Immunoparalysis is linked to increased nosocomial infections and adverse clinical outcomes.
• An increased frequency of non-classical monocytes in sepsis/septic shock patients suggests a potentially better prognosis.